Decision-grade novelty intelligence for R&D — triage early concepts, sharpen them as prior art closes in, and get the scored, sourced read on whether it’s worth filing. Learn more or book a demo: buff.ly/nmDQmHn

Claude Goes Hunting in Viral DNA and Returns With a Possible New Gene Editor: Anthropic's biology lab turned up a previously unknown system in bacteriophages, the viruses that infect bacteria. The system carries repeating DNA that resembles CRISPR... buff.ly/kj1EfuU

Microsoft Hands Its AI a Rulebook, Putting People First: Microsoft AI created a draft Code of Conduct, a 38-page framework that sets the ground rules for its in-house models. The draft is open for public comment for 6 weeks... buff.ly/xHMK0kQ

The Portfolio Intelligence Report scores every patent in a portfolio against the same 14-factor framework, benchmarked against a dynamically generated peer group of the 100 most comparable patents. The result is a ranked view grounded in data.. buff.ly/nSqJvzB

A federal jury has ordered Apple to pay Taction Technology more than $5.7 billion. Taction alleged that the component that creates the taps and vibrations in iPhones & Apple Watches used Taction's patented tactile feedback technology. buff.ly/D0iIeyG

Salesforce has launched Koa, its first CRM reasoning model for Agentforce, showing how the company uses purpose-built AI to help its agents work better. buff.ly/KMZQmEe #AI #Salesforce #Agentforce #EnterpriseAI #LLM #NVIDIA #CRM

We're excited to be at the AI & IP Summit in New York, enjoying the very informative panel discussions. If you attended, share your photo or chime in! #AIandIPUSA

Knowing how an invention stacks up against existing prior art before drafting a single claim keeps teams from investing time and budget in ideas that won't hold up. buff.ly/spyW8ob

Court denies White Mountain's Laches Bid for partial summary judgment in Birkenstock's patent, trademark, and trade dress suit, ruling that factual disputes prevent it from deciding whether laches bars the claims. buff.ly/PZlGixl

An AI-Designed Lung Drug May Also Slow Aging: Insilico Medicine released trial data suggesting a lung-disease drug conceived by the company's AI made patients test biologically younger across all six "aging clocks" it measured. buff.ly/Oj6wHZK

The Computer & Communications Industry Association, with SIIA and other trade groups, has filed an amicus brief urging the Supreme Court to take up Kahoot! v. Interstellar — a case with major implications for companies targeted by patent trolls. buff.ly/pw5V2Uk

Before the Draft: Deciding What Is Worth Patenting in the AI Era. AI can draft a patent application in minutes, but is the underlying invention actually novel and nonobvious enough to justify pursuing protection at all? buff.ly/BHfxFww

The Industry That Shut Itself Down, and the One That Won’t. In February 1975, about 140 of the world’s leading molecular biologists checked into a conference center on the California coast. They spent four days arguing about whether they should be...buff.ly/PZJz6kw

AI Is Patentable Again, For Now. A fast sequence of USPTO actions reopened the door for AI and software claims. The reprieve is real, but not permanent. Here is why patent professionals should not give up on pending AI applications this quarter... Read: buff.ly/chJd0uK

Researchers at the University of Northampton have unleashed CenSegNet, an AI system built to examine breast tumor samples at the cellular level — and it's turning up patterns in cancer progression that had gone completely unnoticed until now. buff.ly/Lphdbln

Claude Proved AI Can Run Real Science Solo. Anthropic released findings showing that Claude carried out protein-design experiments with minimal human intervention—a critical piece of the drug-discovery pipeline—producing functional molecules... buff.ly/9DuxVPI

OpenAI Launches Age-Gated ChatGPT for Teens that auto-enrolls minors into a separate, more restrictive version of ChatGPT. Teens attempting to shortcut homework get steered into Study Mode, which walks them through problems with guiding questions rather... buff.ly/Fh7Gkzk

GREAT WEBINAR! What Is Worth Patenting in the AI Era? Panel: Enrico Monteleone (IBM Master Inventor), Debarshi Nandy (Brandeis University), Sivon Kalminov (Canon U.S.A.), and Joe Manico (Kodak Alaris). Watch it here: buff.ly/BHfxFww

What's Worth Patenting in the AI Era? Join us for a FREE live webinar, hosted by IPWatchdog on Thursday, September 3 at 12:00 PM ET, tackling the question: Is the invention actually worth protecting in the first place? Registration is FREE and OPEN NOW at: buff.ly/Us2aGus

Paul Conyngham raced to save his dog Rosie from terminal cancer using ChatGPT to build a vaccine matched to her tumor's exact mutations. It worked — her tumors shrank. Sam Altman took notice, and now it's a company: Gamgee. Read more here: buff.ly/mhmlExq